Contains one 10858086006266 Cranial Screws, Long, Pouch of 2 and one 10858086006
Contains one 10858086006266 Cranial Screws, Long, Pouch of 2 and one 10858086006273 Cranial Screws, Short, Pouch of 2
Straight 8mm cryoprobefor use with Cryocare systems (Lead-Free)
OCL
Surgical Device, For cutting, coagulation, and/or ablation of tissue, including
Surgical Device, For cutting, coagulation, and/or ablation of tissue, including cardiac tissue
Straight 8mm cryoprobe for use with Cryocare Systems
OCL
Surgical Device, For cutting, coagulation, and/or ablation of tissue, including
Surgical Device, For cutting, coagulation, and/or ablation of tissue, including cardiac tissue
The Calypso System utilizes non-ionizing electromagnetic and optical technology
The Calypso System utilizes non-ionizing electromagnetic and optical technology to provide accurate, objective, and continuous localization of a treatment target for patient alignment and target position monitoring during radiation therapy. Use of the Calypso System for target localization is based on the system’s detection of electromagnetic signals from passive implanted markers, called Beacon transponders. The Beacon transponders are placed on the patient’s skin surface or implanted in or near the treatment target. When used with the Calypso System, the Beacon transponder signals enable objective, continuous measurement of the localization of the treatment target in 3 dimensions. The system operator uses this information for patient alignment and continuous target positioning (i.e., tracking) during radiation therapy treatment.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery during and before external radiotherapy treatment, including IMRT, VMAT and 4DRT (respiratory gating and tumour tracking)• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery during and before external radiotherapy treatment, including IMRT, VMAT and 4DRT (respiratory gating and tumour tracking)• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.
The intended use of the device is• quality assurance of patient specific treatme
The intended use of the device is• quality assurance of patient specific treatment delivery prior to the treatment in IMRT (including VMAT) and 4DRT (e.g. respiratory gating and tumour tracking).• quality assurance of the radiation delivery system.